InvestorsHub Logo
Followers 269
Posts 8494
Boards Moderated 0
Alias Born 10/05/2010

Re: Slojab post# 8670

Sunday, 12/29/2013 2:15:44 PM

Sunday, December 29, 2013 2:15:44 PM

Post# of 8771
DND's management only has themselves to blame for the current pathetic share price. It should have never sunk back to these levels but their lack of communication has ultimately lead to a lack of investor interest.... thus causing a good ole' low volume walkdown.

DND is undervalued IMO, if Bioassaygen is a $2M asset then the pps w/ 24M o/s should realistically be closer to .07 - .09 not even factoring in whatever Cinutri's value is.

However, knowing DND I doubt they will even bother to try and capitalize on this awareness though, I don't expect to hear from them until 2014 sometime...if were lucky....lol.

WELCOME TO